OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Enhancing these processes involves modifying various parameters, including cell line development, media formulation, and bioreactor environments. A key goal is to maximize antibody yield while lowering production cost